There has been an unprecedented eruption of global pharmaceutical research and development related to COVID‑19. More than 330 clinical studies and 80 vaccine candidates are currently under review. Big pharma and biotech companies are working to find a drug to manage or defeat COVID‑19. With the Pharma Opportunity Certificate, you invest in the performance of companies that are actively working on medicines to combat the coronavirus by developing vaccines or treatments.
Subscribe to our Newsletter to receive market news, trade ideas & new themes